Spyre Therapeutics, Inc. (SYRE) Technical Analysis
Updated: 2026-04-20 10:30 UTC · Last close: 73.01 (+4.75%) · Support: 47.06
Spyre Therapeutics, Inc. (SYRE) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
⬇️ Support
47.06
Quick Read
Downside line to hold: 47.06 remains the key nearby support reference.
🔺 Technical Setup
RSI(14)
85.8
📊 Technical Summary
Spyre Therapeutics, Inc. (SYRE) finished the session at 73.01 (+4.75%). Broadly speaking, trend structure still looks constructive because price remains above both the 50-day and 200-day averages. 20-day momentum is notably strong at +72.56%; price is trading in the upper part of its roughly 52-week range (12.42–73.01); and ATR14 volatility is elevated at roughly 7.03% of price. RSI(14) stands near 85.8, suggesting strong bullish momentum with conditions becoming somewhat extended. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD is positioned above the signal line, supporting a still constructive momentum backdrop. The MACD histogram is positive and expanding, pointing to improving upside momentum. The chart is currently flagging Double top. On the downside, 47.06 is the first support area. Holding above it helps keep the current structure more stable. On the fundamentals side, the latest snapshot shows Net income: -155.20M · EPS (basic): 1.06. For a fuller technical read, the interactive view adds overlays, pattern context and broader chart structure.
💼 Fundamentals Snapshot
Source: sec
Company
Spyre Therapeutics, Inc.
CIK (SEC ID)
0001636282
Shares Out.
60.47M
Revenue
0.00
Net Income
-155.20M
EPS (Basic)
1.06
Explore more
Note: This is an algorithmic technical snapshot (not financial advice).